00000cam 2200000zi 4500 9.959619 CaOODSP 20260504161725 m o d f cr cn |||||||| 260205e202604 onc o f000 0 eng d 9780660982663 CaOODSP eng rda CaOODSP n-cn--- H164-418/2026E-PDF Lot Release Program for schedule D (biologic) drugs : revised guidance document for implementation. Ottawa, ON : Health Canada = Santé Canada, April 2026. ©2026 1 online resource (ii, 17 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Lignes directrices sur le Programme d'autorisation de mise en circulation des lots de drogues visées à l'annexe D (produits biologiques) : lignes directrices révisées pour la mise en œuvre. "Pub.: 250442." "This document outlines the Lot Release Program for Schedule D (biologic) drugs. It also covers the extent of the review and testing of biologic drugs prior to their release for sale in Canada by the Biologic and Radiopharmaceutical Drugs Directorate (BRDD)"--Introduction, page 1. Biologicals Government policy Canada. Biologicals Law and legislation Canada. Drug approval Canada. Drugs Testing Government policy Canada. Canada. Health Canada, issuing body. Lignes directrices sur le Programme d'autorisation de mise en circulation des lots de drogues visées à l'annexe D (produits biologiques) : (CaOODSP)9.959620 PDF 712 KB https://publications.gc.ca/collections/collection_2026/sc-hc/H164-418-2026-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/lot-release-program-schedule-d-drugs.html 250442